v3.22.4
CONSOLIDATED STATEMENTS OF INCOME (LOSS) - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]      
Net sales $ 15,113 $ 12,784 $ 11,673
Cost of sales 9,716 7,679 7,086
Gross margin 5,397 5,105 4,587
Selling, general and administrative expenses 3,887 2,867 2,469
Research and development expenses 605 534 521
Goodwill impairments 2,812 0 0
Other operating expense (income), net 36 (6) (19)
Operating income (loss) (1,943) 1,710 1,616
Interest expense, net 395 192 134
Other (income) expense, net 15 41 190
Income (loss) before income taxes (2,353) 1,477 1,292
Income tax expense (benefit) (68) (182) (182)
Net income (loss) (2,421) 1,295 1,110
Net income attributable to noncontrolling interests 12 11 8
Net income (loss) attributable to Baxter stockholders $ (2,433) $ 1,284 $ 1,102
Earnings (loss) per share      
Basic (in dollars per share) $ (4.83) $ 2.56 $ 2.17
Diluted (in dollars per share) $ (4.83) $ 2.53 $ 2.13
Weighted-average number of shares outstanding      
Basic (in shares) 504 502 509
Diluted (in shares) 504 508 517